Exelixis

Morgan Stanley announces Exelixis (NASDAQ:EXEL) $21 price target

legume / July 31, 2023 / Health Care / Exelixis, Morgan Stanley

Morgan Stanley analyst Jefferson Harralson reinstates Exelixis (NASDAQ:EXEL) with a Equal-Weight and announces $21 price target.

Morgan Stanley announces Exelixis (NASDAQ:EXEL) $21 price target Read Post »

Oppenheimer maintains Exelixis (NASDAQ:EXEL) $25 price target

legume / July 31, 2023 / Health Care / Exelixis, Oppenheimer

Oppenheimer analyst Jay Olson reiterates Exelixis (NASDAQ:EXEL) with a Outperform and maintains $25 price target.

Oppenheimer maintains Exelixis (NASDAQ:EXEL) $25 price target Read Post »